The Saroja Pharma IPO commenced on August 31, 2023, and concluded on September 5, 2023. The allotment of shares took place on September 8, 2023, and the initiation of refunds began on September 11, 2023. The shares were credited to the demat accounts of investors on September 12, 2023. Finally, the listing of Saroja Pharma on the stock exchange occurred on September 13, 2023.
The Saroja Pharma IPO was priced at ₹84 per share, with a lot size of 1600. The total issue size was ₹9.11 crores, comprising a fresh issue of ₹9.11 crores. The IPO was listed on the NSE SME.
In terms of quota reservations, the other quota was reserved for 50% of the shares and the retail quota was reserved for 50% of the shares.
Saroja Pharma Industries India Limited IPO Basic Details
|Company Name||Saroja Pharma Industries India Limited|
|Domain of Company||Trade, export, and supply of Specialty Chemicals|
and Active Pharmaceutical Ingredients (APIs)
|Saroja Pharma Industries IPO GMP Today||₹0.00|
|Saroja Pharma Industries IPO Listing Gain||0.00%|
|Saroja Pharma Industries IPO Open Date||August 31, 2023|
|Saroja Pharma Industries IPO Close Date||September 5, 2023|
|Saroja Pharma Industries IPO Allotment Date||September 8, 2023|
|Saroja Pharma Industries IPO Listing Date||September 13, 2023|
|Face Value||₹10 per share|
|Price||₹84 per share|
|Lot Size||1600 Shares|
|Issue Size||1,084,800 shares of ₹10|
(aggregating up to ₹9.11 Cr)
|Fresh Issue||1,084,800 shares of ₹10|
(aggregating up to ₹9.11 Cr)
|Issue Type||Fixed Price Issue IPO|
|Listing At||NSE SME|
|Company Promoters||Mr. Biju Gopinathan Nair And|
Mr. Manish Dasharath Kamble
Saroja Pharma IPO GMP Today:
|Date||GMP||Listing Gain||Kostak||Subject to|
|6 September 2023||₹0||0.00%||–||–|
|5 September 2023||₹0||0.00%||–||–|
|4 September 2023||₹0||0.00%||–||–|
|3 September 2023||₹0||0.00%||–||–|
|2 September 2023||₹0||0.00%||–||–|
|1 September 2023||₹0||0.00%||–||–|
|31 August 2023||₹0||0.00%||–||–|
Saroja Pharma IPO Details:
Established in 2019, Saroja Pharma Industries India Limited specializes in the trading, exporting, and distribution of Specialty Chemicals and Active Pharmaceutical Ingredients (APIs). The company operates within three primary product categories: Chemicals, Pharma Intermediaries, and Veterinary Pharma API. Their product portfolio includes items like Liquid Bromine, employed as an agricultural intermediate, as well as Ethyl Acetate, utilized as an API solvent. Additionally, they supply various pharmaceutical products, both for human and veterinary use, some of which serve as API solvents.
APIs, also known as bulk drugs or bulk actives, are the core constituents in the production of finished dosages, such as capsules, tablets, liquids, and other dosage forms, sometimes combined with other APIs or inert ingredients.
Saroja Pharma Industries India Limited primarily exports its products to destinations like Pakistan, Egypt, Russia, Jordan, Hong Kong, and Singapore.
Key Competitive Advantages:
- A seasoned team of promoters and management professionals.
- A scalable business model designed for growth.
- A comprehensive and diversified range of products.
- Varied business operations contributing to a diverse revenue base.
Saroja Pharma IPO More Details Click Here
Saroja Pharma IPO FAQs
When is Saroja Pharma IPO open?
Saroja Pharma IPO will open on 31 August 2023.
When is Saroja Pharma IPO Close?
Saroja Pharma IPO will be closed on 5 September 2023.
What is Saroja Pharma IPO GMP Today?
The Saroja Pharma IPO GMP aka Grey Market Premium is ₹0.
What is Saroja Pharma IPO Kostak Rates Today?
The Saroja Pharma IPO Kostak Rate is ₹000.
What is Saroja Pharma IPO Subject to Sauda Price Today?
The Saroja Pharma IPO subject to sauda rates is ₹000.
Saroja Pharma IPO Expected Returns?
The Saroja Pharma expected return is 0%.
How much will be the listing gain in Saroja Pharma IPO?
Saroja Pharma IPO will get listing gain of 0%. (Approx.)